Literature DB >> 25786451

Anaplastic thyroid carcinoma accompanied by uncontrollable eosinophilia.

Jun Shiraishi1, Hidenori Koyama, Miwako Seki, Miki Hatayama, Mariko Naka, Masafumi Kurajoh, Hirokazu Okazaki, Takuhito Shoji, Yuji Moriwaki, Tetsuya Yamamoto, Yasuaki Tsuchida, Yoshitane Tsukamoto, Seiichi Hirota, Naoyoshi Onoda, Mitsuyoshi Namba.   

Abstract

Anaplastic thyroid carcinoma is a rare disease, and cases associated with eosinophilia are even rarer. We herein report a case of anaplastic thyroid carcinoma accompanied by remarkable and uncontrollable eosinophilia. A 71-year-old man was diagnosed with end-stage anaplastic thyroid carcinoma. Throughout the aggressive clinical course of the cancer, eosinophilia dramatically progressed and became extremely refractory to steroid treatment. We measured the serum levels of hematopoietic cytokines potentially involved in eosinophilia, including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3 and IL-5. Although the GM-CSF level was moderately elevated, both the IL-3 and IL-5 levels were within the normal ranges. In this case, the patient's eosinophilia may have been related to his severe dyspnea and was likely responsible for the allergic reaction to the anticancer drug. Therefore, it is essential to elucidate the etiology of eosinophilia in patients with thyroid cancer in order to improve the treatment for patients with anaplastic thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25786451     DOI: 10.2169/internalmedicine.54.3446

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

Review 1.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

2.  Excessive Leukocytosis Leading to a Diagnosis of Aggressive Thyroid Anaplastic Carcinoma: A Case Report and Relevant Review.

Authors:  Antonis Polymeris; Christina Kogia; Dimitrios Ioannidis; Dimitrios Lilis; Maria Drakou; Nicoletta Maounis; Loukas Kaklamanis; Sofia Tseleni-Balafouta
Journal:  Eur Thyroid J       Date:  2020-04-09

Review 3.  The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.

Authors:  Gilda Varricchi; Stefania Loffredo; Giancarlo Marone; Luca Modestino; Poupak Fallahi; Silvia Martina Ferrari; Amato de Paulis; Alessandro Antonelli; Maria Rosaria Galdiero
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

4.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

5.  Be(a)ware of Leukocytosis in Papillary Thyroid Cancer.

Authors:  Styliani Laskou; Konstantinos Sapalidis; Christos Topalidis; Triantafyllia Koletsa; Isaak Kesisoglou
Journal:  Case Rep Endocrinol       Date:  2022-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.